Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 16.62
+0.22 (1.34%)
Aug 27, 2026, 1:35 PM CST
SHA:600521 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,886 | 1,504 | 1,537 | 1,342 | 1,365 | 1,876 |
Trading Asset Securities | 75.23 | 75.98 | 60.79 | 93.04 | 143.07 | 1.01 |
Cash & Short-Term Investments | 1,962 | 1,580 | 1,597 | 1,435 | 1,508 | 1,877 |
Cash Growth | 14.62% | -1.07% | 11.28% | -4.82% | -19.66% | -15.13% |
Accounts Receivable | 3,168 | 3,172 | 3,235 | 2,557 | 2,831 | 1,906 |
Other Receivables | 13.92 | 40.04 | 38.76 | 28.4 | 47.43 | 40.85 |
Receivables | 3,182 | 3,212 | 3,274 | 2,585 | 2,879 | 1,947 |
Inventory | 3,596 | 3,712 | 3,413 | 3,432 | 3,375 | 2,739 |
Prepaid Expenses | - | - | 5.11 | 4.25 | - | - |
Other Current Assets | 225.25 | 237.32 | 193.06 | 164.61 | 145.35 | 250.18 |
Total Current Assets | 8,965 | 8,742 | 8,483 | 7,622 | 7,907 | 6,813 |
Property, Plant & Equipment | 9,554 | 9,472 | 8,571 | 7,994 | 7,307 | 5,961 |
Long-Term Investments | 873.55 | 770.06 | 796.17 | 785.25 | 863.17 | 1,027 |
Goodwill | 65.84 | 64.45 | 64.45 | 64.45 | 70.9 | 70.9 |
Other Intangible Assets | 1,129 | 1,158 | 1,196 | 1,113 | 1,072 | 970.6 |
Long-Term Deferred Tax Assets | 186.09 | 194.78 | 189.67 | 171.99 | 183.9 | 110.15 |
Long-Term Deferred Charges | 1,169 | 1,098 | 960.16 | 843.04 | 737.88 | 508.28 |
Other Long-Term Assets | 2.8 | 2.93 | 1.09 | 6.45 | 9.46 | 7.87 |
Total Assets | 21,945 | 21,503 | 20,261 | 18,600 | 18,152 | 15,468 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,550 | 1,807 | 1,585 | 1,387 | 1,203 | 881.79 |
Accrued Expenses | 175.21 | 907.8 | 997.44 | 735.43 | 898.42 | 791.6 |
Short-Term Debt | 2,692 | 2,860 | 2,110 | 1,583 | 1,397 | 1,314 |
Current Portion of Long-Term Debt | 3,135 | 3,231 | 943.47 | 1,191 | 630.76 | 630.99 |
Current Portion of Leases | - | 29.29 | 14.11 | 16.82 | 16.72 | 13.82 |
Current Income Taxes Payable | 121.17 | 36.39 | 81.68 | 91.14 | 264.11 | 187.9 |
Current Unearned Revenue | 64.5 | 34.99 | 54.4 | 33.51 | 67.7 | 66.71 |
Other Current Liabilities | 819.62 | 205.22 | 189.5 | 407.71 | 321.64 | 348.93 |
Total Current Liabilities | 8,558 | 9,112 | 5,976 | 5,445 | 4,799 | 4,236 |
Long-Term Debt | 2,373 | 1,841 | 4,394 | 4,022 | 4,678 | 3,498 |
Long-Term Leases | 5.26 | 75.64 | 16.99 | 44.93 | 59.14 | 66.41 |
Long-Term Unearned Revenue | 659.32 | 661.84 | 698.95 | 665.44 | 532.09 | 448.44 |
Other Long-Term Liabilities | 304.31 | 356.02 | 155.9 | 171.02 | 338 | 443.51 |
Total Liabilities | 11,900 | 12,047 | 11,241 | 10,349 | 10,406 | 8,692 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,497 | 1,497 | 1,467 | 1,483 | 1,483 | 1,492 |
Additional Paid-In Capital | 1,338 | 1,610 | 1,185 | 1,296 | 1,322 | 1,381 |
Retained Earnings | 6,817 | 6,195 | 6,301 | 5,470 | 4,992 | 3,971 |
Treasury Stock | -100.01 | -100.01 | -300.05 | -416.91 | -484.25 | -521.84 |
Comprehensive Income & Other | 227.06 | 240.17 | 244.47 | 244.43 | 233.98 | 236.54 |
Total Common Equity | 9,779 | 9,443 | 8,898 | 8,077 | 7,547 | 6,559 |
Minority Interest | 266.41 | 13.35 | 122.25 | 174.26 | 199.07 | 217.48 |
Shareholders' Equity | 10,045 | 9,456 | 9,020 | 8,251 | 7,746 | 6,776 |
Total Liabilities & Equity | 21,945 | 21,503 | 20,261 | 18,600 | 18,152 | 15,468 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8,206 | 8,038 | 7,478 | 6,858 | 6,782 | 5,523 |
Net Cash (Debt) | -6,244 | -6,457 | -5,881 | -5,422 | -5,273 | -3,646 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -4.20 | -4.36 | -4.05 | -3.72 | -3.61 | -2.54 |
Filing Date Shares Outstanding | 1,468 | 1,490 | 1,449 | 1,468 | 1,473 | 1,484 |
Total Common Shares Outstanding | 1,468 | 1,490 | 1,449 | 1,468 | 1,473 | 1,484 |
Working Capital | 406.61 | -370.11 | 2,507 | 2,176 | 3,109 | 2,577 |
Book Value Per Share | 6.66 | 6.18 | 5.97 | 5.34 | 4.96 | 4.26 |
Tangible Book Value | 8,583 | 8,220 | 7,637 | 6,899 | 6,403 | 5,517 |
Tangible Book Value Per Share | 5.85 | 5.35 | 5.10 | 4.54 | 4.18 | 3.56 |
Buildings | - | 5,523 | 4,527 | 3,757 | 2,839 | 2,151 |
Machinery | - | 6,990 | 6,228 | 5,546 | 152.08 | 3,827 |
Construction In Progress | - | 1,987 | 2,188 | 2,317 | 2,803 | 2,502 |